Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus among Patients with Systemic Lupus Erythematosus: A Population‐Based Study

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d8834279e99">To evaluate the association between adherence to antimalarials and type 2 diabetes mellitus (DM) in patients with systemic lupus erythematosus (SLE). </p>

Related collections

Author and article information

Journal

Title: Arthritis Care & Research

Abbreviated Title: Arthritis Care Res

Publisher: Wiley

ISSN (Print): 2151-464X

ISSN (Electronic): 2151-4658

Publication date Created: January 21 2020

Publication date (Electronic): January 21 2020

Affiliations

[1 ]University of British Columbia Faculty of Pharmaceutical Sciences Vancouver BC Canada

[2 ]Arthritis Research Canada Richmond BC Canada

[3 ]Collaboration for Outcomes Research and Evaluation Vancouver BC Canada

[4 ]University of British Columbia Faculty of Medicine Department of Medicine Division of Rheumatology Vancouver BC Canada

Article

DOI: 10.1002/acr.24147

PubMed ID: 31961497

SO-VID: 1fbafedd-2132-4746-836e-d58691a1514d

License:

http://onlinelibrary.wiley.com/termsAndConditions#vor

http://doi.wiley.com/10.1002/tdm_license_1.1

History

Data availability:

Comments

Comment on this article

scite_

Cited by 6

See all cited by

- Version 1